Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches

Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches

  • Mithun Rudrapal
  • Chukwuebuka Egbuna
Publisher:ElsevierISBN 13: 9780323914338ISBN 10: 0323914330

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks WagonGOBook ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books ₹180Audible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches is written by Mithun Rudrapal and published by Elsevier. It's available with International Standard Book Number or ISBN identification 0323914330 (ISBN 10) and 9780323914338 (ISBN 13).

Computer-Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches outlines the basic theoretical principles, methodologies and applications of different fundamental and advanced CADD approaches and techniques. Including information on current protocols as well as recent developments in the computational methods, tools and techniques used for rational drug design, the book explains the fundamental aspects of CADD, combining this with a practical understanding of the various in silico approaches used in modern drug discovery processes to assess the field in a comprehensive and systematic manner. Providing up-to-date, information and guidance for scientists, researchers, students and teachers, the book helps readers address specific academic and research related problems using illustrative explanations, examples and case studies, which are systematically reviewed. - Highlights in silico approaches to drug design and discovery using computational tools and techniques - Details ligand-based and structure-based drug design in a comprehensive and systematic approach - Summarizes recent developments in computational drug design strategy as novel approaches of rational drug designing